Status:
COMPLETED
The Effect of Myopic Optical Defocus on the Humphrey Matrix 30-2 Test
Lead Sponsor:
Samsung Medical Center
Conditions:
Myopia
Eligibility:
All Genders
27-61 years
Brief Summary
The purpose of this study is to examine the effect of the myopic optical defocus on the Humphrey Matrix 30-2 test.
Detailed Description
The Humphery Matrix (Zeiss, Dublin, California, USA; in cooperation with Welch Allyn, Skaneateles, New York, USA), which is a recently developed version of FDT perimetry, showed more improved technolo...
Eligibility Criteria
Inclusion
- intra-ocular pressure 23 or higher
- suspicious glaucomatous optic disc change
- suspicious defect of retinal nerve fiber layer
- or eyes with various degrees of glaucoma
Exclusion
- a high myopic eye (SE more than -6.0 D)
- moderate to severe cataract
- evidence of diabetic or hypertensive retinopathy
- macular disease
- intra-ocular inflammation
- history of intraocular surgery and any other ocular lesion that could have an influence on the perimetry result
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00638430
Start Date
March 1 2007
End Date
March 1 2008
Last Update
March 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 130-710